[1] HERMANN P,APPLEBY B,BRANDEL J P,et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease[J]. Lancet Neurol,2021,20(3):235-246.
[2] CARROLL J A,CHESEBRO B. Neuroinflammation,microglia,and cell-association during prion disease[J]. Viruses,2019,11(1):65.
[3] AGUZZI A,ZHU C. Microglia in prion diseases[J]. J Clin Invest,2017,127(9):3230-3239.
[4] BARTOLETTI-STELLA A,CORRADO P,MOMETTO N,et al. Analysis of RNA expression profiles identifies dysregulated vesicle trafficking pathways in Creutzfeldt-Jakob disease[J]. Mol Neurobiol,2019,56(7):5009-5024.
[5] KANG S G,KIM C,CORTEZ L M,et al. Toll-like receptor-mediated immune response inhibits prion propagation[J]. Glia,2016,64(6):937-951.
[6] DAS D,LUO X,SINGH A,et al. Paradoxical role of prion protein aggregates in redox-iron induced toxicity[J]. PLoS One,2010,5(7):e11420.
[7] LLORENS F,LOPEZ-GONZALEZ I,THUNE K,et al. Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease[J]. Front Aging Neurosci,2014,6:198.
[8] LIU S,LIU Y,HAO W,et al. TLR2 is a primary receptor for Alzheimer′s amyloid beta peptide to trigger neuroinflammatory activation[J]. J Immunol,2012,188(3):1098-1107.
[9] MA X,WANG Y,YIN H,et al. Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson′s disease rats via regulation of TLR/NF-kappaB signaling pathway[J]. Brain Res Bull,2021,174:22-30.
[10] LI Z,LIU Y,JIA A,et al. Cerebrospinal fluid cells immune landscape in multiple sclerosis[J]. J Transl Med,2021,19(1):125.
[11] VEERHUIS R,NIELSEN H M,TENNER A J. Complement in the brain[J]. Mol Immunol,2011,48(14):1592-1603.
[12] ALAWIEH A,LANGLEY E F,WEBER S,et al. Identifying the role of complement in triggering neuroinflammation after traumatic brain injury[J]. J Neurosci,2018,38(10):2519-2532.
[13] VASEK M J,GARBER C,DORSEY D,et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment[J]. Nature,2016,534(7608):538-543.
[14] GREWAL R P,MORGAN T E,FINCH C E. C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis[J]. Neurosci Lett,1999,271(1):65-67.
[15] KHAN S Q,KHAN I,GUPTA V. CD11b activity modulates pathogenesis of lupus nephritis[J]. Front Med(Lausanne),2018,5:52.
[16] ZHANG D,HU X,QIAN L,et al. Microglial MAC1 receptor and PI3K are essential in mediating beta-amyloid peptide-induced microglial activation and subsequent neurotoxicity[J]. J Neuroinflammation,2011,8(1):3.
[17] ZHU X,LIU X,LIU Y,et al. Uncovering the potential differentially expressed miRNAs and mRNAs in ischemic stroke based on integrated analysis in the gene expression omnibus database[J]. Eur Neurol,2020,83(4):404-414.
[18] XU H,JIA J. Immune-related hub genes and the competitive endogenous RNA network in Alzheimer′s disease[J]. J Alzheimers Dis,2020,77(3):1255-1265.
[19] TAJMIM A,CUEVAS-OCAMPO A K,SIDDIQUE A B,et al. (-)-Oleocanthal nutraceuticals for Alzheimer′s disease amyloid pathology:novel oral formulations,therapeutic,and molecular insights in 5xFAD transgenic mice model[J]. Nutrients,2021,13(5):1702.
[20] PROPSON N E,ROY E R,LITVINCHUK A,et al. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging[J]. J Clin Invest,2021,131(1):e140966.
[21] XIE Y,LUO X,HE H,et al. Novel insight into the role of immune dysregulation in amyotrophic lateral sclerosis based on bioinformatic analysis[J]. Front Neurosci,2021,15:657465.